Administration of cetuximab in managing colorectal cancer
Clinical Previous     Next

Administration of cetuximab in managing colorectal cancer

Tamas Hickish Consultant medical oncologist, Dorset Cancer Centre

This article outlines the management strategy for the administration of the new anti-cancer drug cetuximab (Erbitux) in this case to private patients in Dorset using an independent service provider (Healthcare at Home) to administer the drug. Use of cetuximab in cancer care seems set to increase and this will place significant demand on the capacity of chemotherapy units. A strategy of home administration – or perhaps in a satellite chemotherapy unit – after initial exposure is feasible

Cancer Nursing Practice. 5, 4,28-29. doi: 10.7748/cnp2006.05.5.4.28.c194

Conflict of interest

The author has received honoraria from Pfizer and Merck, and hospitality from Healthcare at Home

Peer review

This article has been subject to double blind peer review

You need a subscription to read the full article